WallStreetZenWallStreetZen

NASDAQ: GALT
Galectin Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Galectin Therapeutics earnings were -$37.4M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest GALT earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$8.2M, up 8.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GALT reported annual earnings of -$47.2M, with 5.3% growth. The next GALT earnings date is Mar 26, 2026.

GALT earnings history

Current Revenue
$0.0
Current Earnings
-$37.4M
Current Profit Margin
0%

GALT Return on Equity

Insufficient data to display

GALT Return on Assets

Current Company
-269.9%
Current Industry
-8.8%
GALT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GALT announces earnings.

GALT Return on Capital Employed

Current Company
24.43%
Current Industry
-3.5%
GALT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GALT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GALT-$30.17M-$37.44MN/A-$0.59
TNXP-$97.29M-$99.22M-83.80%$279.11
CAMP-$49.81M-$53.40MN/A$63.67
CCCC-$110.30M-$119.08MN/A-$1.67
ZNTL-$148.62M-$149.32MN/A-$2.07
View Top Biotech Stocks

GALT earnings dates

Next earnings date
Mar 26, 2026

Galectin Therapeutics Earnings Reports & History FAQ

What were Galectin Therapeutics's earnings last quarter?

On GALT's earnings call on Invalid Date, Galectin Therapeutics (NASDAQ: GALT) reported Q3 2025 earnings per share (EPS) of -$0.13, up 27.78% year over year. Total GALT earnings for the quarter were -$8.22 million. In the same quarter last year, Galectin Therapeutics's earnings per share (EPS) was -$0.18.

If you're new to stock investing, here's how to buy Galectin Therapeutics stock.

When does Galectin Therapeutics report earnings?

The next GALT earnings call is Invalid Date. Add GALT to your watchlist to be reminded of Galectin Therapeutics's next earnings date.

Is Galectin Therapeutics profitable or losing money?

As of the last Galectin Therapeutics earnings report, Galectin Therapeutics is currently losing money. Galectin Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$37.30 million, a 17.25% decrease year over year.

What was GALT's earnings growth in the past year?

As of Galectin Therapeutics's earnings date in Invalid Date, Galectin Therapeutics's earnings has grown year over year. GALT earnings in the past year totalled -$37.44 million.

What are Galectin Therapeutics's earnings expectations?

The current EPS estimate for Galectin Therapeutics's earnings report in Invalid Date is -$0.10.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.